Bio-Rad Laboratories, Inc.

BIO

$304.06

Name : Bio-Rad Laboratories, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $8,201,968,640.00

EPSttm : -24.02

Bio-Rad Laboratories, Inc.

$304.06

2.90%

$9.09

Float Short %

5.15

Margin Of Safety %

-24

Put/Call OI Ratio

2.37

EPS Next Q Diff

0.28

EPS Last/This Y

75.41

EPS This/Next Y

0.29

Price

304.13

Target Price

355

Analyst Recom

Performance Q

5.44

Relative Volume

0.72

Beta

1.19

Ticker: BIO

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	BIO	321.9	1.81	0.40	627
2025-10-21	BIO	331.57	1.80	0.67	632
2025-10-22	BIO	334.1	1.78	3.75	640
2025-10-23	BIO	338.54	1.82	0.13	654
2025-10-24	BIO	340.07	1.76	25.00	662
2025-10-27	BIO	336.12	1.95	0.00	714
2025-10-28	BIO	330.57	2.95	0.00	967
2025-10-29	BIO	319.78	2.98	7.57	964
2025-10-30	BIO	304.16	2.62	23.18	920
2025-10-31	BIO	319.8	2.62	0.00	919
2025-11-03	BIO	311.46	2.54	0.00	927
2025-11-04	BIO	311.2	2.55	0.00	926
2025-11-05	BIO	310.01	2.56	999.99	925
2025-11-06	BIO	306.68	2.56	999.99	925
2025-11-07	BIO	305.46	2.56	999.99	926
2025-11-10	BIO	307.38	2.67	999.99	954
2025-11-11	BIO	313.2	2.67	999.99	954
2025-11-12	BIO	327.11	2.67	1.40	955
2025-11-13	BIO	316.75	2.56	0.00	955
2025-11-14	BIO	313.23	2.57	0.11	954
2025-11-17	BIO	303.93	2.37	1.50	984
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	BIO	321.98	-3.9	-177.1	9.56
2025-10-21	BIO	331.28	-3.9	-177.9	9.56
2025-10-22	BIO	333.97	-3.9	-182.9	9.56
2025-10-23	BIO	338.40	-3.9	-180.9	9.56
2025-10-24	BIO	339.74	-3.9	-183.3	9.56
2025-10-27	BIO	336.01	-3.9	-187.6	9.56
2025-10-28	BIO	330.42	-3.9	-190.0	9.56
2025-10-29	BIO	319.41	-3.9	-196.0	9.56
2025-10-30	BIO	304.61	-3.9	-201.8	9.56
2025-10-31	BIO	319.55	-3.9	1127.3	9.56
2025-11-03	BIO	311.46	3.4	1095.0	10.40
2025-11-04	BIO	311.29	-2.6	1119.0	10.05
2025-11-05	BIO	310.21	-2.6	1118.4	10.05
2025-11-06	BIO	306.57	-2.6	1114.8	10.05
2025-11-07	BIO	305.56	-2.6	1116.8	10.05
2025-11-10	BIO	307.38	-2.6	1119.5	10.05
2025-11-11	BIO	313.33	-2.6	1124.3	10.05
2025-11-12	BIO	327.33	-2.6	1133.7	10.05
2025-11-13	BIO	317.02	-2.6	1111.4	10.05
2025-11-14	BIO	313.20	-2.6	1116.0	10.05
2025-11-17	BIO	304.13	-2.6	1108.0	10.05
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	BIO	0.00	0.36	4.55
2025-10-21	BIO	0.00	0.36	4.55
2025-10-22	BIO	0.00	0.36	4.55
2025-10-23	BIO	0.00	0.36	4.55
2025-10-24	BIO	0.00	0.36	4.55
2025-10-27	BIO	0.00	1.63	6.10
2025-10-28	BIO	0.00	1.63	6.10
2025-10-29	BIO	0.00	1.63	6.11
2025-10-30	BIO	0.00	1.63	6.11
2025-10-31	BIO	0.00	1.63	6.11
2025-11-03	BIO	0.00	1.90	6.13
2025-11-04	BIO	0.00	1.90	6.13
2025-11-05	BIO	0.00	1.90	6.13
2025-11-06	BIO	0.00	1.90	6.13
2025-11-07	BIO	0.00	1.90	6.13
2025-11-10	BIO	-0.01	3.07	6.13
2025-11-11	BIO	-0.01	3.07	6.13
2025-11-12	BIO	-0.01	3.07	5.10
2025-11-13	BIO	-0.01	3.07	5.10
2025-11-14	BIO	-0.01	3.07	5.15
2025-11-17	BIO	-0.01	-3.25	5.15
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

2.26

Avg. EPS Est. Current Quarter

2.82

Avg. EPS Est. Next Quarter

2.54

Insider Transactions

-0.01

Institutional Transactions

-3.25

Beta

1.19

Average Sales Estimate Current Quarter

706

Average Sales Estimate Next Quarter

601

Fair Value

229.87

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

63.5

Max Drawdown 5-Year %

-73.8

Target Price

355

P/E

Forward P/E

27.94

PEG

P/S

3.21

P/B

1.22

P/Free Cash Flow

24.37

EPS

-24.3

Average EPS Est. Cur. Y

10.05

EPS Next Y. (Est.)

10.33

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-26.43

Relative Volume

0.72

Return on Equity vs Sector %

-37

Return on Equity vs Industry %

-28

EPS 1 7Days Diff

0.5

EPS 1 30Days Diff

0.49

EBIT Estimation

1108

Bio-Rad Laboratories, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 7700

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

stock quote shares BIO – Bio-Rad Laboratories, Inc. Stock Price stock today

news today BIO – Bio-Rad Laboratories, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch BIO – Bio-Rad Laboratories, Inc. yahoo finance google finance

stock history BIO – Bio-Rad Laboratories, Inc. invest stock market

stock prices BIO premarket after hours

ticker BIO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: BIO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y